Sign in Subscribe
Birth defects

mRNA COVID-19 Vaccine Exposure in First Trimester Found Safe for Babies

Strategic Insights

— 1 min read

Researchers have investigated the link between first-trimester mRNA COVID-19 vaccine exposure and major structural birth defects in live-born infants. The analysis, published in JAMA Pediatrics, included 42,156 singleton pregnancies with live birth from March 5, 2021, to January 25, 2022. The findings suggest that first-trimester mRNA COVID-19 vaccine exposure is not associated with an increased risk for selected major structural birth defects.

Key Takeaways:

  • The study assessed the risk of selected major structural birth defects among live-born infants exposed to mRNA COVID-19 vaccine during the first trimester.
  • The analysis included 42,156 singleton pregnancies with live birth from eight health systems across California, Oregon, Washington, Colorado, Minnesota, and Wisconsin.
  • The researchers found that selected major structural birth defects occurred in 1.48% of infants after first-trimester mRNA COVID-19 vaccination and in 1.41% of infants without first-trimester vaccine exposure.
  • The adjusted prevalence ratio was 1.02, with a 95% confidence interval of 0.78 to 1.33, indicating no significant difference between exposed and unexposed groups.
  • The study's findings support the safety of maternal COVID-19 vaccination in the first trimester.
  • Several authors disclosed ties to industry.

Statistics:

  • 42,156 singleton pregnancies with live birth were included in the analysis.
  • The study period spanned from March 5, 2021, to January 25, 2022.
  • 1.48% of infants developed selected major structural birth defects after first-trimester mRNA COVID-19 vaccination.
  • 1.41% of infants without first-trimester vaccine exposure developed selected major structural birth defects.
  • The adjusted prevalence ratio was 1.02 with a 95% confidence interval of 0.78 to 1.33.

Sources:

  • Kharbanda EO, et al. (2024, July 1). Association of receipt of mRNA COVID-19 vaccine during the first trimester with live-born infant outcomes. JAMA Pediatrics. (Source: JAMA Pediatrics, July 1, 2024)

Read more